This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

CardioNet, Inc., IMEC And Delta Partner To Develop Next Generation Cardiac Monitoring Products

CardioNet, Inc. (NASDAQ:BEAT), the leading wireless medical technology and research services company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today announced a multi-year development agreement with the Belgium-based nanoelectronics research center IMEC and its Dutch affiliate Holst Centre. Over the next 18 months, the Companies will work to develop two revolutionary cardiac monitoring products.

The new products are expected to greatly improve the patient experience during monitoring, and to be a major advance in the field of remote cardiac monitoring. CardioNet expects the development project to build on its proprietary algorithms and back-end infrastructure, and IMEC’s world-leading expertise in ultra-low power ECG readout ASIC (application specific integrated circuit) with integrated motion artifact reduction. The project will also leverage Denmark-based Delta's development of the world's smallest ECG electrode patch.

“Ten years ago, CardioNet revolutionized the field of cardiac monitoring by introducing the first mobile outpatient cardiac telemetry system, MCOT TM. Today, CardioNet is once again pioneering the field, by developing innovative solutions in terms of user experience and performance,” commented Luc Van den hove, President and CEO of IMEC. “We are delighted to see how our ultra-low power integrated circuits translate to such system innovations, and are excited to work with CardioNet. This collaboration is another example of how leading companies are leveraging our technologies to launch new products with breakthrough performance and functionality, addressing the most pressing challenges in healthcare.”

Joe Capper, President and CEO of CardioNet, commented: “We are excited to join forces with IMEC to develop the next generation of cardiac monitoring devices. In selecting IMEC as our development partner, we were extremely impressed with IMEC’s proven track record of developing innovative products for a distinguished group of global partners. This collaboration will further advance the use of remote technology to improve the quality of patient care.”

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs